Core Insights - Nike's fiscal fourth-quarter sales and profits declined year-over-year, but the results were better than analysts expected, indicating progress in the company's turnaround plan [1][2] - Revenue fell 12% year-over-year to $11.1 billion, while net income dropped to $211 million, or 14 cents per share, down from $1.5 billion, or 99 cents per share, in the previous year [1] - The results mark the third quarter under CEO Elliott Hill, who took over in October, and the company anticipates improvements moving forward as its portfolio shifts begin to take effect [2] Financial Performance - Revenue for the quarter was $11.1 billion, a 12% decrease from the previous year [1] - Net income decreased to $211 million, or 14 cents per share, compared to $1.5 billion, or 99 cents per share, in the same quarter last year [1] - Despite the decline, both revenue and net income exceeded analyst expectations [1] Market Reaction - Nike shares fell approximately 1% in extended trading following the earnings report [3] - The stock has experienced a 17% decline for the year 2025 up to Thursday's close [3]

Calgary, Alberta--(Newsfile Corp. - June 26, 2025) - Canadian Critical Minerals Inc. (TSXV: CCMI) (OTCQB: RIINF) ("CCMI" or the "Company") announces that, pursuant to its stock option plan, the Company has granted 8,000,000 incentive stock options at an exercise price of $0.05 per share and an expiry date of three years from the date of issue to certain directors, officers and employees of the Company. About Canadian Critical Minerals Inc.CCMI is a mining company primarily focused on copper production asse ...

VANCOUVER, British Columbia, June 26, 2025 (GLOBE NEWSWIRE) -- Westport Fuel Systems Inc. (TSX: WPRT / Nasdaq: WPRT) (“Westport” or “The Company”) announces that the Company will release Q2 2025 financial results on Monday, August 11, 2025, after market close. A conference call and webcast to discuss the financial results and other corporate developments will be held on Tuesday, August 12, 2025. Time: 10:00 a.m. ET (7:00 a.m. PT)Call Link: https://register-conf.media-server.com/register/BI842f3b76bd5b44c7ae ...

EnglishItalianoEspañolPortuguêsDeutschالعربيةFrançaisImportant DisclaimersThe content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial decision, you should perform your ...

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Digimarc Corporation regarding a class action lawsuit due to alleged misleading statements and failure to disclose critical information during a specified class period [1][3]. Summary by Relevant Sections Class Period and Allegations - The class period for the lawsuit is from May 3, 2024, to February 26, 2025 [3]. - Allegations include that Digimarc's management made materially false and misleading statements, specifically regarding: 1. A significant commercial partner's decision not to renew a large contract on the same terms. 2. The need for Digimarc to renegotiate this large commercial contract. 3. The adverse impact on the company's subscription revenue and annual recurring revenue due to the renegotiation. 4. Misleading positive statements about the company's business and prospects as a result of the above issues [3]. Next Steps for Shareholders - Shareholders are encouraged to register for the class action by July 7, 2025, to participate in the case without any cost or obligation [4]. - Upon registration, shareholders will receive updates through a portfolio monitoring software regarding the case's progress [4]. Law Firm's Mission - The Gross Law Firm aims to protect investors' rights against deceit, fraud, and illegal business practices, ensuring companies adhere to responsible business practices [5].

Core Viewpoint - Rocket Pharmaceuticals, Inc. is facing a class action lawsuit due to allegations of providing misleading statements regarding the safety and clinical trial protocol of its RP-A501 treatment, which resulted in significant stock price decline after the FDA placed a clinical hold on the study following a Serious Adverse Event [3][4]. Summary by Relevant Sections Allegations - The complaint alleges that Rocket Pharmaceuticals made overwhelmingly positive statements while concealing material adverse facts about RP-A501's safety and clinical trial protocol, including the risk of Serious Adverse Events (SAEs) and participant deaths [3]. - The company amended the trial protocol to include a new immunomodulatory agent without informing shareholders, leading to artificially inflated stock prices [3]. - Following the announcement of the FDA's clinical hold on May 27, 2025, due to a patient's death linked to the trial, Rocket's stock price plummeted from $6.27 to $2.33, a decline of approximately 37% in one trading day [3]. Class Action Details - The class period for the lawsuit is from February 27, 2025, to May 26, 2025, with a deadline for shareholders to register as lead plaintiffs by August 11, 2025 [4]. - Shareholders who register will receive updates on the case's progress through portfolio monitoring software [4]. Law Firm Information - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud, seeking recovery for losses incurred due to misleading statements by companies [5].

Core Viewpoint - Vestis Corporation is facing a class action lawsuit due to allegations of providing misleading statements about its business growth and performance, leading to a significant drop in stock price following disappointing financial results [3][4]. Summary by Relevant Sections Allegations - The complaint against Vestis Corporation claims that the company made overwhelmingly positive statements while concealing material adverse facts about its business growth capabilities [3]. - Specifically, it is alleged that Vestis would be unable to execute planned strategic initiatives aimed at improving customer experience and driving new customer growth [3]. Financial Performance - On May 7, 2025, Vestis announced its second-quarter financial results for fiscal 2025, withdrawing its revenue and growth guidance for the full year [3]. - The company reported that its poor performance was due to "lost business in excess of new business" and "lower adds over stops," indicating a decline in volume changes with existing customers [3]. - Following this announcement, Vestis' stock price plummeted from $8.71 per share on May 6, 2025, to $5.44 per share on May 7, 2025, marking a decline of approximately 37.54% in just one day [3]. Class Action Details - Shareholders who purchased shares of Vestis during the class period from May 2, 2024, to May 6, 2025, are encouraged to register for the class action lawsuit [4]. - The deadline for shareholders to seek lead plaintiff status is August 8, 2025, and there is no cost or obligation to participate in the case [4]. Law Firm Information - The Gross Law Firm, which is handling the class action, is a nationally recognized firm dedicated to protecting investors' rights against deceit and fraud [5].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Compass Group Diversified Holdings, LLC (NYSE: CODI) regarding a class action lawsuit due to alleged failures in financial reporting and internal controls [1][3]. Summary by Relevant Sections Allegations - The complaint alleges that Compass failed to disclose effective internal controls over financial reporting and critical information regarding its subsidiary, Lugano Holding, Inc. This included undisclosed financing arrangements and irregularities in sales, cost of sales, inventory, and accounts receivable [3]. - The truth about these issues emerged on May 7, 2025, when Compass announced that its financial statements for fiscal 2024 could no longer be relied upon due to an internal investigation into Lugano [3]. - Following this announcement, Compass's stock price plummeted from $17.25 per share on May 7, 2025, to $6.55 per share on May 8, 2025 [3]. Next Steps for Shareholders - Shareholders who purchased shares of CODI during the class period (February 24, 2022, to May 7, 2025) are encouraged to register for the class action by July 8, 2025 [4]. - Once registered, shareholders will be enrolled in a portfolio monitoring software to receive updates throughout the case [4]. Law Firm's Commitment - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting the rights of investors who have suffered due to deceit, fraud, and illegal business practices [5]. - The firm aims to ensure that companies adhere to responsible business practices and seeks recovery for investors affected by misleading statements or omissions that led to stock inflation [5].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Organon & Co. regarding a class action lawsuit due to misleading statements and a significant reduction in quarterly dividends, which led to a sharp decline in stock price [1][3]. Summary by Relevant Sections Class Action Details - Shareholders who purchased Organon shares between October 31, 2024, and April 30, 2025, are encouraged to contact the firm for potential lead plaintiff appointment [1][4]. - The allegations include that the defendants made overly positive statements while concealing material adverse facts about the company's capital allocation priorities, particularly regarding debt reduction after the acquisition of Dermavant [3]. Financial Impact - Following the revelation of the company's debt reduction strategy, Organon's regular quarterly dividend was reduced by 70%, causing the stock price to drop from $12.93 per share on April 30, 2025, to $9.45 per share on May 1, 2025, representing a decline of over 27% in one day [3]. Next Steps for Shareholders - The deadline for shareholders to register for the class action is July 22, 2025, and those who register will receive updates through a portfolio monitoring software [4]. - Participation in the case does not incur any cost or obligation for the shareholders [4]. Firm's Commitment - The Gross Law Firm aims to protect investors' rights and ensure companies adhere to responsible business practices, seeking recovery for losses incurred due to misleading statements [5].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of 3D Systems Corporation regarding a class action lawsuit due to alleged misleading statements and omissions made by the company during a specified class period [1][3]. Summary by Relevant Sections Class Period and Allegations - The class period for the lawsuit is from August 13, 2024, to May 12, 2025 [3]. - Allegations include that 3D Systems understated the impact of weakened customer spending and overstated its resilience in challenging industry conditions [3]. - Additionally, the updated milestone criteria in the partnership with United Therapeutics Corporation are claimed to negatively impact the company's regenerative medicine program revenue [3]. Next Steps for Shareholders - Shareholders are encouraged to register for the class action by the deadline of August 12, 2025, to potentially become lead plaintiffs [4]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the case [4]. Law Firm's Commitment - The Gross Law Firm aims to protect investors' rights and seeks recovery for those who suffered losses due to deceitful practices by companies [5]. - The firm emphasizes the importance of responsible business practices and good corporate citizenship [5].